Relapsed Multiple Myeloma
Oncology·MeSH: Multiple Myeloma
Prevalence
17.0 / 100K
Incidence
7.0 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Frequently asked questions
How many drugs are in development for Relapsed Multiple Myeloma?
BioSniper tracks 1 drug in development for Relapsed Multiple Myeloma across 1 company.
How many clinical trials target Relapsed Multiple Myeloma?
There are 3 clinical trials targeting Relapsed Multiple Myeloma tracked by BioSniper.
What is the prevalence of Relapsed Multiple Myeloma?
The estimated prevalence of Relapsed Multiple Myeloma is approximately 17.0 per 100,000 population.
Deep-dive into Relapsed Multiple Myeloma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis